MMP13 and breast carcinoma: Expression of the double or triple mutants of RUNX2 in breast cancer cells reduces the mRNA levels of two metastasis-related target genes, MMP9 and MMP13, and reduces the RUNX2-dependent invasive potential of breast cancer cells.